| Literature DB >> 12518890 |
Tatsuyuki Takada1, Yutaka Suzuki, Yasushi Kondo, Nae Kadota, Kinji Kobayashi, Shinji Nito, Hiroshi Kimura, Ryuzo Torii.
Abstract
The major limitation of nonhuman primate (NHP) embryonic stem (ES) cell research is inefficient genetic modification and limited knowledge of differentiation mechanisms. A genetically modified NHP-ES cell with biomarkers, such as green fluorescent protein (GFP), that allow noninvasive monitoring of transgenic cells, is a useful tool to study cell differentiation control during preimplantation and fetal development, which also plays a crucial role in the development of cell transplantation medicine. Here we report the establishment of transgenic NHP-ES cell lines that express GFP without jeopardizing their pluripotency, which was confirmed by in vitro and in vivo differentiation. These GFP-expressing ES cells reproducibly differentiated into embryoid bodies, neural cells, and cardiac myocytes. They formed teratoma composed of tissues derived from the three embryonic germ layers when transplanted into severe combined immunodeficient disease (SCID) mice. GFP expression was maintained in these differentiated cells, suggesting that these cells were useful for cell transplantation experiments. Furthermore, we showed that these ES cells have the ability to form chimeric blastocysts by introducing into the early preimplantation stage NHP embryo.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12518890 DOI: 10.3727/000000002783985350
Source DB: PubMed Journal: Cell Transplant ISSN: 0963-6897 Impact factor: 4.064